4basebio PLC (4BB.L)
GBp 1110.9
(-3.82%)
GBp 1110.9
(-3.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.24 Million | -4.7 Million | -2.74 Million | -1.02 Million | -269 Thousand |
| Net Income | -7.66 Million | -5.15 Million | -3.23 Million | -719 Thousand | -423 Thousand |
| Depreciation & Amortization | 709 Thousand | 431 Thousand | 320 Thousand | 277 Thousand | 251 Thousand |
| Deferred income taxes | - | -128 Thousand | -80 Thousand | - | - |
| Stock-based compensation | 223 Thousand | 128 Thousand | 80 Thousand | - | - |
| Change in working capital | 384 Thousand | 168 Thousand | 455 Thousand | -809 Thousand | -38 Thousand |
| Other non-cash items | 1.36 Million | -153 Thousand | -280 Thousand | 229 Thousand | -59 Thousand |
| Investing Cash Flow | -1.49 Million | -1.94 Million | -1.51 Million | 1.44 Million | -203 Thousand |
| Investments in PPE | -1.49 Million | -1.94 Million | -1.51 Million | -849 Thousand | -203 Thousand |
| Acquisitions | - | - | - | 2.29 Million | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -619 Thousand | -786 Thousand | -628 Thousand | -498 Thousand | -800 Thousand |
| Financing Cash Flow | 6.49 Million | 1.24 Million | -467 Thousand | 14.42 Million | 487 Thousand |
| Debt repayment | -6.58 Million | -1.41 Million | -331 Thousand | -1.02 Million | -629 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2000.00 | - | - | 15.62 Million | - |
| Other Financing Activities | -65 Thousand | 2.65 Million | -136 Thousand | -175 Thousand | 1.11 Million |
| Accounts receivables | -109 Thousand | 140 Thousand | -126 Thousand | 91 Thousand | 116 Thousand |
| Accounts payables | 695 Thousand | -2000.00 | 615 Thousand | -876 Thousand | -167 Thousand |
| Inventory | -202 Thousand | 30 Thousand | -34 Thousand | -24 Thousand | 13 Thousand |
| Other working capital | 695 Thousand | - | - | - | - |
| Cash at beginning of period | 4.35 Million | 9.58 Million | 15 Million | 80 Thousand | 69 Thousand |
| Cash at end of period | 3.06 Million | 4.35 Million | 9.58 Million | 15 Million | 80 Thousand |
| Capital Expenditure | -1.49 Million | -1.94 Million | -1.51 Million | -849 Thousand | -203 Thousand |
| Effect of forex changes on cash | -39 Thousand | 166 Thousand | -696 Thousand | 70 Thousand | -4000.00 |
| Net cash flow / Change in cash | -1.28 Million | -5.23 Million | -5.41 Million | 14.92 Million | 11 Thousand |
| Free Cash Flow | -7.73 Million | -6.64 Million | -4.25 Million | -1.87 Million | -472 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.86 Million | -2.86 Million | -2.05 Million | -7.66 Million | -2.05 Million | -3.55 Million |
| Depreciation & Amortization | 256.5 Thousand | 256.5 Thousand | 189 Thousand | 709 Thousand | 188.5 Thousand | 331 Thousand |
| Deferred income taxes | - | - | - | - | - | -907.3 Thousand |
| Stock-based compensation | 174 Thousand | 174 Thousand | 68.19 Thousand | 223 Thousand | 68.19 Thousand | 43.3 Thousand |
| Change in working capital | -44.5 Thousand | -44.5 Thousand | -68.5 Thousand | 384 Thousand | -68.5 Thousand | -202 Thousand |
| Other non-cash items | -92.5 Thousand | -92.5 Thousand | 270.8 Thousand | 1.36 Million | 271.3 Thousand | 1.27 Million |
| Investing Cash Flow | -347.5 Thousand | -347.5 Thousand | -377 Thousand | -1.49 Million | -377 Thousand | -736 Thousand |
| Investments in PPE | -94 Thousand | -94 Thousand | -232.5 Thousand | -1.49 Million | -232.5 Thousand | -736 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -253.5 Thousand | -253.5 Thousand | -144.5 Thousand | -619 Thousand | -144.5 Thousand | -165 Thousand |
| Financing Cash Flow | 2.74 Million | 2.74 Million | 1.65 Million | 6.49 Million | 1.65 Million | 3.14 Million |
| Debt repayment | -4.84 Million | - | -3.39 Million | -6.58 Million | - | -3.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 742 Thousand | - | - | 2000.00 | - | 2000.00 |
| Other Financing Activities | 2.74 Million | 2.74 Million | 1.65 Million | -65 Thousand | 1.65 Million | 1.55 Million |
| Accounts receivables | -27.5 Thousand | -27.5 Thousand | -2500.00 | -109 Thousand | -2500.00 | -104 Thousand |
| Accounts payables | -180 Thousand | - | 723 Thousand | 695 Thousand | - | -28 Thousand |
| Inventory | -17 Thousand | -17 Thousand | -66 Thousand | -202 Thousand | -66 Thousand | -70 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.06 Million | - | 3.55 Million | 4.35 Million | - | 4.35 Million |
| Cash at end of period | 2.71 Million | -175.5 Thousand | 3.06 Million | 3.06 Million | -244.5 Thousand | 3.55 Million |
| Capital Expenditure | -94 Thousand | -94 Thousand | -232.5 Thousand | -1.49 Million | -232.5 Thousand | -736 Thousand |
| Effect of forex changes on cash | -6000.00 | -6000.00 | 72.5 Thousand | -39 Thousand | 72.5 Thousand | -92 Thousand |
| Net cash flow / Change in cash | -351 Thousand | -175.5 Thousand | -489 Thousand | -1.28 Million | -244.5 Thousand | -793 Thousand |
| Free Cash Flow | -2.66 Million | -2.66 Million | -1.82 Million | -7.73 Million | -1.82 Million | -3.74 Million |
EC
0QKB
ECAOF
XPL
MGX
QRC